{"id":"clm_994B784F55A6","entity":"gilead-sciences","predicate":"total_equity","value":"22,703,000,000 United States dollar","value_json":{"fy":2025,"accn":"0000882095-26-000006","form":"10-K","filed":"2026-02-24","concept":"us-gaap:StockholdersEquity"},"valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Gilead Sciences total equity: 22,703,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_994B784F55A6, https://asof.is/claim/clm_994B784F55A6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/0000882095-26-000006-index.htm.","url":"https://asof.is/claim/clm_994B784F55A6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E5496920DE7C","supersedes":["clm_B2A4004D2607"],"first_seen_at":"2026-11-08T15:39:34.353214+00:00","updated_at":"2026-11-08T15:39:41.883733+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/0000882095-26-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2025, filed 2026-02-24"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}